Hubei Goto Biopharm Co.,Ltd. (SHE:300966)

Hubei Goto Biopharm Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	2,484	1,859	2,648	3,112	4,729	-
Market Cap Growth	34.14%	-29.78%	-14.93%	-34.18%	-	-
Enterprise Value	3,744	2,838	3,321	3,500	4,781	-
Last Close Price	21.58	16.13	22.95	26.98	40.79	-
PE Ratio	-	-	115.10	77.42	60.37	-
PS Ratio	3.97	3.47	4.68	5.15	8.00	-
PB Ratio	2.59	1.83	2.59	3.17	5.71	-
P/TBV Ratio	3.02	2.13	2.94	3.52	6.07	-
P/OCF Ratio	-	-	38.86	-	81.52	-
EV/Sales Ratio	5.98	5.29	5.86	5.79	8.09	-
EV/EBITDA Ratio	73.41	100.45	62.18	50.18	55.11	-
EV/EBIT Ratio	-	-	123.29	77.00	74.15	-
Debt / Equity Ratio	1.33	1.12	0.77	0.79	0.20	0.28
Debt / EBITDA Ratio	24.88	39.68	14.25	10.60	1.84	1.81
Asset Turnover	0.23	0.21	0.25	0.37	0.59	0.58
Inventory Turnover	1.17	1.12	1.09	1.16	1.56	1.63
Quick Ratio	0.39	0.44	0.61	1.26	1.37	1.39
Current Ratio	1.02	0.95	1.27	2.11	2.58	2.35
Return on Equity (ROE)	-5.28%	-3.11%	2.12%	4.37%	11.41%	10.42%
Return on Assets (ROA)	-0.10%	-0.35%	0.74%	1.73%	4.00%	4.73%
Return on Invested Capital (ROIC)	-0.22%	-0.81%	1.84%	4.38%	8.12%	9.11%
Return on Capital Employed (ROCE)	-0.20%	-0.70%	1.50%	3.00%	7.30%	11.00%
Earnings Yield	-1.85%	-1.48%	0.87%	1.29%	1.66%	-
FCF Yield	-9.82%	-17.87%	-12.88%	-13.88%	-0.70%	-
Dividend Yield	-	-	0.07%	-	0.33%	-
Payout Ratio	-	-	26.49%	66.92%	9.67%	17.20%
Buyback Yield / Dilution	4.04%	0.05%	-0.13%	-8.77%	-22.87%	-0.08%
Total Shareholder Return	4.04%	0.05%	-0.06%	-8.77%	-22.54%	-0.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.